What Does the Future Hold For The Biotech Industry?

Biotech stocks have had a good five years. Over this period, the MVIS™ US Listed Biotech 25 Index has risen 193.71%. But the period has had its ups and downs.

So, what does the future hold for the biotech industry? If nothing else, the election last November of Donald Trump as U.S. American president has put some wind in its sails. The sources of this have included positive expectations on three different fronts:

1. Decreased regulation
2. Expedited approvals by the U.S. Food and Drug Administration (FDA)
3. Innovation in new classes of immunotherapies

Much excitement in the industry stems from the possible use of immunotherapies to fight cancer. According to a recent article in the Wall Street Journal (quoting figures from the Cancer Research Institute), more than 1,100 different immunotherapy drugs are currently the subject of research.

For this alone, it looks as though biotechnology will, therefore, be an interesting industry to follow for some time yet.

Related:

• MarketVector™ Crypto Heat Index — Measuring Market Temperature
• Gold Miners Strike Gold in 2025; Prospecting for 2026
• Price vs. Psychology: Why $100K Bitcoin Feels So Different This Time